Your browser doesn't support javascript.
loading
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.
Coleman, Robert L; Lorusso, Domenica; Gennigens, Christine; González-Martín, Antonio; Randall, Leslie; Cibula, David; Lund, Bente; Woelber, Linn; Pignata, Sandro; Forget, Frederic; Redondo, Andrés; Vindeløv, Signe Diness; Chen, Menghui; Harris, Jeffrey R; Smith, Margaret; Nicacio, Leonardo Viana; Teng, Melinda S L; Laenen, Annouschka; Rangwala, Reshma; Manso, Luis; Mirza, Mansoor; Monk, Bradley J; Vergote, Ignace.
Afiliação
  • Coleman RL; US Oncology Research, The Woodlands, TX, USA. Electronic address: rcoleman@gog.org.
  • Lorusso D; Multicentre Italian Trials in Ovarian Cancer and Gynaecological Malignancies Group and Scientific Directorate and Department of Women and Child Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Gennigens C; Department of Medical Oncology, Centre Hospitalier Universitaire de Liège, Liège, Belgium.
  • González-Martín A; Grupo Español de Investigación en Cáncer de Ovario and Department of Medical Oncology, Clínica Universidad de Navarra, Madrid, Spain.
  • Randall L; Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA.
  • Cibula D; Central and Eastern European Gynecologic Oncology Group and Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
  • Lund B; Aalborg University Hospital, Aalborg, Denmark.
  • Woelber L; Arbeitsgemeinschaft Gynäkologische Onkologie Study Group and University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Pignata S; Multicentre Italian Trials in Ovarian Cancer and Gynaecological Malignancies Group and Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione G Pascale" IRCCS, Naples, Italy.
  • Forget F; Centre Hospitalier de l'Ardenne, Libramont, Belgium.
  • Redondo A; Grupo Español de Investigación en Cáncer de Ovario and Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.
  • Vindeløv SD; Genmab, Copenhagen, Denmark.
  • Chen M; Genmab US, Princeton, NJ, USA.
  • Harris JR; Genmab US, Princeton, NJ, USA.
  • Smith M; Genmab US, Princeton, NJ, USA.
  • Nicacio LV; Seagen, Bothell, WA, USA.
  • Teng MSL; Seagen, Bothell, WA, USA.
  • Laenen A; Belgium and Luxembourg Gynaecological Oncology Group and University of Leuven, Leuven Cancer Institute, Leuven, Belgium.
  • Rangwala R; Genmab US, Princeton, NJ, USA.
  • Manso L; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Mirza M; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
  • Monk BJ; Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine, Phoenix, AZ, USA.
  • Vergote I; Belgium and Luxembourg Gynaecological Oncology Group and University of Leuven, Leuven Cancer Institute, Leuven, Belgium.
Lancet Oncol ; 22(5): 609-619, 2021 05.
Article em En | MEDLINE | ID: mdl-33845034
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Neoplasias do Colo do Útero / Anticorpos Monoclonais Humanizados / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Neoplasias do Colo do Útero / Anticorpos Monoclonais Humanizados / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido